Related Experiment Video
Updated: Aug 8, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
New genetics of Burkitt's lymphoma and other non-Hodgkin's lymphomas
Abstract:
Recent progress in cytogenetics and molecular genetics allows striking new insight into Burkitt's lymphoma. In this B cell tumor, the oncogene c-myc located on the long arm of chromosome 8 translocates to one of three locations: adjacent to the immunoglobulin heavy chain gene on chromosome 14, adjacent to the gene for the kappa light chain of immunoglobulin on chromosome 2, or adjacent to the gene for the lambda light chain on chromosome 22. Nucleotide sequence analysis indicates that the translocated c-myc is usually upstream of an immunoglobulin constant region gene, although the exact position varies. In its new location, the oncogene is actively transcribed and may have escaped its normal control mechanisms. It can be no coincidence that this B cell lymphoma is intimately associated with a misadventure in the genetic underpinnings of the major event in B cell differentiation, the assembling of a functional immunoglobulin molecule. Similar genetic catastrophes probably account for the more common B cell lymphomas and could provide the basis of a coherent lymphoma classification.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

